Skin Neoplasms

"Skin Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the SKIN.

Descriptor ID	D012878
MeSH Number(s)	C04.588.805 C17.800.882
Concept/Terms	Skin Neoplasms Skin Neoplasms Neoplasms, Skin Neoplasm, Skin Skin Neoplasm Cancer of Skin Cancer of Skin Skin Cancers Cancer of the Skin Skin Cancer Cancer, Skin Cancers, Skin

Below are MeSH descriptors whose meaning is more general than "Skin Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Skin Neoplasms [C04.588.805]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Skin Neoplasms [C17.800.882]

Below are MeSH descriptors whose meaning is related to "Skin Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Skin Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Skin Neoplasms" by people in this website by year, and whether "Skin Neoplasms" was a major or minor topic of these publications.

Bar chart showing 2157 publications over 31 distinct years, with a maximum of 113 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	17	1	18
1993	13	9	22
1994	26	5	31
1995	32	4	36
1996	22	7	29
1997	33	4	37
1998	43	3	46
1999	29	5	34
2000	38	9	47
2001	47	3	50
2002	65	4	69
2003	68	12	80
2004	50	6	56
2005	62	11	73
2006	78	12	90
2007	73	6	79
2008	82	5	87
2009	67	7	74
2010	81	10	91
2011	104	9	113
2012	87	8	95
2013	82	9	91
2014	78	20	98
2015	82	10	92
2016	78	11	89
2017	103	7	110
2018	96	9	105
2019	74	5	79
2020	92	7	99
2021	84	6	90
2022	45	2	47

Below are the most recent publications written about "Skin Neoplasms" by people in Profiles.

Srivastava A, Tommasi C, Sessions D, Mah A, Bencomo T, Garcia JM, Jiang T, Lee M, Shen JY, Seow LW, Nguyen A, Rajapakshe K, Coarfa C, Tsai KY, Lopez-Pajares V, Lee CS. MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET. Cancer Res. 2022 Sep 02; 82(17):3143-3157.

View in: PubMed
Navsaria LJ, Li Y, Nowakowska MK, Hinkston CL, Wheless L, Giordano SH, Wehner MR. Incidence and Treatment of Actinic Keratosis in Older Adults With Medicare Coverage. JAMA Dermatol. 2022 Sep 01; 158(9):1076-1078.

View in: PubMed
Kim EJ, Mangold AR, DeSimone JA, Wong HK, Seminario-Vidal L, Guitart J, Appel J, Geskin L, Lain E, Korman NJ, Zeitouni N, Nikbakht N, Dawes K, Akilov O, Carter J, Shinohara M, Kuzel TM, Piette W, Bhatia N, Musiek A, Pariser D, Kim YH, Elston D, Boh E, Duvic M, Huen A, Pacheco T, Zwerner JP, Lee ST, Girardi M, Querfeld C, Bohjanen K, Olsen E, Wood GS, Rumage A, Donini O, Haulenbeek A, Schaber CJ, Straube R, Pullion C, Rook AH, Poligone B. Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical Trial. JAMA Dermatol. 2022 Sep 01; 158(9):1031-1039.

View in: PubMed
Olsen EA, Whittaker S, Willemze R, Pinter-Brown L, Foss F, Geskin L, Schwartz L, Horwitz S, Guitart J, Zic J, Kim YH, Wood GS, Duvic M, Ai W, Girardi M, Gru A, Guenova E, Hodak E, Hoppe R, Kempf W, Kim E, Lechowicz MJ, Ortiz-Romero P, Papadavid E, Quaglino P, Pittelkow M, Prince HM, Sanches JA, Sugaya M, Vermeer M, Zain J, Knobler R, Stadler R, Bagot M, Scarisbrick J. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood. 2022 08 04; 140(5):419-437.

View in: PubMed
Di Carlo V, Stiller CA, Eisemann N, Bordoni A, Matz M, Curado MP, Daubisse-Marliac L, Valkov M, Bulliard JL, Morrison D, Johnson C, Girardi F, Marcos-Gragera R, Šekerija M, Larønningen S, Sirri E, Coleman MP, Allemani C. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1?578?482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3). Br J Dermatol. 2022 09; 187(3):364-380.

View in: PubMed
Rothrock AT, Torres-Cabala CA, Milton DR, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Ivan D, Prieto VG, Aung PP. Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesions. J Cutan Pathol. 2022 Oct; 49(10):859-867.

View in: PubMed
Buja A, Rugge M, De Luca G, Zorzi M, Cozzolino C, Vecchiato A, Del Fiore P, Tropea S, Bortolami A, Benini P, Rossi CR, Mocellin S. Clinical performance indicators for monitoring the management of cutaneous melanoma: a population-based perspective. Melanoma Res. 2022 10 01; 32(5):353-359.

View in: PubMed
Pemmaraju N, Sweet KL, Stein AS, Wang ES, Rizzieri DA, Vasu S, Rosenblat TL, Brooks CL, Habboubi N, Mughal TI, Kantarjian H, Konopleva M, Lane AA. Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm. J Clin Oncol. 2022 Sep 10; 40(26):3032-3036.

View in: PubMed
Rothrock AT, Truong LD, Shehabeldin A, Wong MKK, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Torres-Cabala CA, Prieto VG, Aung PP. Amyloid deposition with a granulomatous reaction in a resection specimen: A clue for a pre-existing Merkel cell carcinoma. J Cutan Pathol. 2022 Sep; 49(9):787-790.

View in: PubMed
Silk AW, Barker CA, Bhatia S, Bollin KB, Chandra S, Eroglu Z, Gastman BR, Kendra KL, Kluger H, Lipson EJ, Madden K, Miller DM, Nghiem P, Pavlick AC, Puzanov I, Rabinowits G, Ruiz ES, Sondak VK, Tavss EA, Tetzlaff MT, Brownell I. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer. J Immunother Cancer. 2022 07; 10(7).

View in: PubMed

People

Explore

Similar Concepts

Top Journals